Drug intelligence / Profile preview

oxygen + ozone

Development stage
Phase 4
Modality
Small Molecules
Administration
Injection, Autohemotherapy, Insufflation, Intravenous, Intramuscular, Topical
01

Overview

Oxygen + ozone refers to a combination of medical-grade oxygen (O2) and ozone (O3) gases used in alternative medicine as "ozone therapy." Ozone is a triatomic form of oxygen with strong oxidizing properties. In this context, the mixture is administered via various routes—such as injection, autohemotherapy (mixing blood with the gas and reinfusing), or insufflation—to purportedly increase tissue oxygenation, modulate immune responses, reduce inflammation, and inactivate pathogens. The proposed mechanisms include stimulation of red blood cell metabolism for improved tissue oxygen delivery; modulation of cytokine production by immunocompetent cells; downregulation of oxidative stress; and direct antimicrobial effects against bacteria, viruses, fungi, and protozoa[1][3][5][8]. Despite its use for conditions like circulatory disorders, chronic inflammatory diseases (e.g., rheumatoid arthritis), infections (including viral diseases), wound healing support, autoimmune diseases, chronic pain syndromes (e.g., fibromyalgia), diabetic ulcers, cardiovascular disease adjunctive care—and even cancer support—there is insufficient high-quality evidence supporting safety or efficacy. Major regulatory agencies such as the FDA prohibit its use due to toxicity concerns at therapeutic doses[1][2][6]. Adverse effects can be severe if inhaled or improperly administered.

Other names
oxygen-ozone therapyoxygen/ozone mixtureO2/O3 therapy
02

Targets

Viral lipid envelopePGN (Peptidoglycan)

Beyond the preview

Go deeper on oxygen + ozone.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on oxygen + ozone.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call